Differential effect of ritonavir and indinavir on immune response to hepatitis C virus in HIV-1 infected patients.
Michelet
C
C
Chapplain
J M
JM
Petsaris
O
O
Arvieux
C
C
Ruffault
A
A
Lotteau
V
V
André
P
P
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000276:immunology* / Q000821:virology; D017320:HIV Protease Inhibitors / Q000494:pharmacology*; D016174:Hepacivirus / Q000187:drug effects / Q000235:genetics / Q000276:immunology; D006526:Hepatitis C / Q000188:drug therapy / Q000276:immunology* / Q000821:virology; D006801:Humans; D007109:Immunity / Q000187:drug effects; D019469:Indinavir / Q000494:pharmacology / Q000627:therapeutic use; D012189:Retrospective Studies; D019438:Ritonavir / Q000494:pharmacology*; D019258:Saquinavir / Q000494:pharmacology / Q000627:therapeutic use
D017320:HIV Protease Inhibitors; D019469:Indinavir; D019258:Saquinavir; D019438:Ritonavir